Literature DB >> 24273401

Role of pharmacogenomic biomarkers in predicting and improving drug response: part 1: the clinical significance of pharmacogenetic variants.

C Lee Ventola.   

Abstract

As genotyping and genetic testing become more sophisticated, accessible, and costeffective, these tools hold great promise for predicting and improving responses to medications.

Year:  2013        PMID: 24273401      PMCID: PMC3828931     

Source DB:  PubMed          Journal:  P T        ISSN: 1052-1372


  11 in total

Review 1.  Personalized medicine: hope or hype?

Authors:  Keyan Salari; Hugh Watkins; Euan A Ashley
Journal:  Eur Heart J       Date:  2012-06-01       Impact factor: 29.983

Review 2.  Individual response to drug therapy: bases and study approaches.

Authors:  Rafael Baltazar Reyes León-Cachón; Jorge Angel Ascacio-Martínez; Hugo Alberto Barrera-Saldaña
Journal:  Rev Invest Clin       Date:  2012 Jul-Aug       Impact factor: 1.451

Review 3.  Where are we today with personalized medicine?

Authors:  Robert H Howland
Journal:  J Psychosoc Nurs Ment Health Serv       Date:  2012-10-15       Impact factor: 1.098

Review 4.  Future prospects for pharmacogenetics in the quest for personalized medicine.

Authors:  Robert H Howland
Journal:  J Psychosoc Nurs Ment Health Serv       Date:  2012-12       Impact factor: 1.098

5.  The pharmacogenetics of symptom response to antipsychotic drugs.

Authors:  Gavin P Reynolds
Journal:  Psychiatry Investig       Date:  2012-01-09       Impact factor: 2.505

Review 6.  Clinical application of pharmacogenomics.

Authors:  Joseph D Ma; Kelly C Lee; Grace M Kuo
Journal:  J Pharm Pract       Date:  2012-06-11

Review 7.  Relating human genetic variation to variation in drug responses.

Authors:  Ashraf G Madian; Heather E Wheeler; Richard Baker Jones; M Eileen Dolan
Journal:  Trends Genet       Date:  2012-07-26       Impact factor: 11.639

Review 8.  Pharmacogenomics discovery and implementation in genome-wide association studies era.

Authors:  Xiuqin Ni; Wei Zhang; R Stephanie Huang
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2012-11-27

Review 9.  Personalizing medicine with clinical pharmacogenetics.

Authors:  Stuart A Scott
Journal:  Genet Med       Date:  2011-12       Impact factor: 8.822

10.  Chapter 7: Pharmacogenomics.

Authors:  Konrad J Karczewski; Roxana Daneshjou; Russ B Altman
Journal:  PLoS Comput Biol       Date:  2012-12-27       Impact factor: 4.475

View more
  20 in total

1.  Assessment of the clinical utility of pharmacogenetic guidance in a comprehensive medication management service.

Authors:  Idaliz Rodríguez-Escudero; Julio A Cedeño; Ileana Rodríguez-Nazario; Gledys Reynaldo-Fernández; Leyanis Rodríguez-Vera; Niretzy Morales; Braulio Jiménez-Vélez; Gualberto Ruaño; Jorge Duconge
Journal:  J Am Coll Clin Pharm       Date:  2020-05-02

Review 2.  Do genetics contribute to TNF inhibitor response prediction in Psoriatic Arthritis?

Authors:  Philippa D K Curry; Andrew P Morris; Anne Barton; James Bluett
Journal:  Pharmacogenomics J       Date:  2022-10-15       Impact factor: 3.245

3.  Further extensions of precision medicine to behavior analysis: A demonstration using functional communication training.

Authors:  John Michael Falligant; Louis P Hagopian
Journal:  J Appl Behav Anal       Date:  2020-07-21

4.  Physicians' Knowledge and Attitudes Regarding Point-of-Care Pharmacogenetic Testing: A Hospital-Based Cross-Sectional Study.

Authors:  Suhaib Muflih; Osama Y Alshogran; Sayer Al-Azzam; Ghaith Al-Taani; Yousef S Khader
Journal:  Pharmgenomics Pers Med       Date:  2021-06-01

5.  Initial assessment of the benefits of implementing pharmacogenetics into the medical management of patients in a long-term care facility.

Authors:  Juan-Sebastian Saldivar; David Taylor; Elaine A Sugarman; Ali Cullors; Jorge A Garces; Kahuku Oades; Joel Centeno
Journal:  Pharmgenomics Pers Med       Date:  2016-01-19

6.  Projected impact of a multigene pharmacogenetic test to optimize medication prescribing in cardiovascular patients.

Authors:  Olivia M Dong; Amy Li; Oscar Suzuki; Akinyemi Oni-Orisan; Ricardo Gonzalez; George A Stouffer; Craig R Lee; Tim Wiltshire
Journal:  Pharmacogenomics       Date:  2018-05-25       Impact factor: 2.533

Review 7.  Future Directions of Pharmacovigilance Studies Using Electronic Medical Recording and Human Genetic Databases.

Authors:  Young Hee Choi; Chang Yeob Han; Kwi Suk Kim; Sang Geon Kim
Journal:  Toxicol Res       Date:  2019-10-15

Review 8.  XPO1-dependent nuclear export as a target for cancer therapy.

Authors:  Nancy G Azizian; Yulin Li
Journal:  J Hematol Oncol       Date:  2020-06-01       Impact factor: 17.388

9.  CYP2B6*6 Genotype Specific Differences in Artemether-Lumefantrine Disposition in Healthy Volunteers.

Authors:  Sa'ad T Abdullahi; Julius O Soyinka; Adeniyi Olagunju; Rahman A Bolarinwa; Olusola J Olarewaju; Moji T Bakare-Odunola; Markus Winterberg; Joel Tarning; Andrew Owen; Saye Khoo
Journal:  J Clin Pharmacol       Date:  2019-09-23       Impact factor: 3.126

10.  The utility of pharmacogenetic testing to support the treatment of bipolar disorder.

Authors:  Marta Ielmini; Nicola Poloni; Ivano Caselli; Jordi Espadaler; Miquel Tuson; Alessandro Grecchi; Camilla Callegari
Journal:  Pharmgenomics Pers Med       Date:  2018-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.